Page last updated: 2024-10-26

dipyridamole and Blastocyst Disintegration

dipyridamole has been researched along with Blastocyst Disintegration in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"Plasmic 6-keto-PGF1a was low."1.32[Endothelium and platelets in pregnant women with chronic glomerulonephritis and therapeutic efficacy of acetylsalicylic acid and dipiridamol]. ( Artem'eva, VB; Gordovskaia, NB; Kozlovskaia, NL; Krylova, MIu; Rogov, VA; Shilov, EM; Sidorova, IS, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rogov, VA1
Shilov, EM1
Kozlovskaia, NL1
Gordovskaia, NB1
Sidorova, IS1
Krylova, MIu1
Artem'eva, VB1

Other Studies

1 other study available for dipyridamole and Blastocyst Disintegration

ArticleYear
[Endothelium and platelets in pregnant women with chronic glomerulonephritis and therapeutic efficacy of acetylsalicylic acid and dipiridamol].
    Terapevticheskii arkhiv, 2004, Volume: 76, Issue:12

    Topics: Administration, Oral; Aspirin; Biomarkers; Blood Platelets; Dipyridamole; Embryo Loss; Endothelium;

2004